Jean Roy

8.4k total citations · 2 hit papers
163 papers, 5.9k citations indexed

About

Jean Roy is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Jean Roy has authored 163 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Hematology, 43 papers in Oncology and 30 papers in Molecular Biology. Recurrent topics in Jean Roy's work include Hematopoietic Stem Cell Transplantation (54 papers), Multiple Myeloma Research and Treatments (26 papers) and Lymphoma Diagnosis and Treatment (12 papers). Jean Roy is often cited by papers focused on Hematopoietic Stem Cell Transplantation (54 papers), Multiple Myeloma Research and Treatments (26 papers) and Lymphoma Diagnosis and Treatment (12 papers). Jean Roy collaborates with scholars based in Canada, United States and France. Jean Roy's co-authors include Thierry Façon, Michel Attal, Philippe Casassus, Hervé Maisonneuve, Norbert Ifrah, Catherine Payen, Jean‐François Rossi, Jean Pouliot, Éric Vigneault and Denis‐Claude Roy and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Jean Roy

153 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

1996 2.0k citations Jean Roy et al. profile →
Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

2003 699 citations Jean Roy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean Roy Canada	32	3.6k	2.2k	2.0k	899	551	163	5.9k
Bronno van der Holt Netherlands	51	3.1k 0.9×	2.1k 1.0×	3.0k 1.5×	853 0.9×	966 1.8×	224	7.8k
John N. Lukens United States	39	911 0.3×	1.9k 0.9×	1.5k 0.8×	763 0.8×	949 1.7×	204	7.1k
Florian Länger Germany	41	1.3k 0.3×	2.0k 0.9×	944 0.5×	854 0.9×	916 1.7×	276	5.8k
Judith Sandbank Israel	33	940 0.3×	1.3k 0.6×	1.5k 0.8×	1.0k 1.1×	782 1.4×	138	5.5k
Robert W. McKenna United States	41	2.3k 0.6×	601 0.3×	1.7k 0.8×	1.4k 1.5×	508 0.9×	118	5.8k
Francesco Di Raimondo Italy	48	3.7k 1.0×	3.0k 1.4×	2.8k 1.4×	1.3k 1.4×	717 1.3×	375	8.6k
Antonio Martı́nez Spain	45	423 0.1×	1.5k 0.7×	2.8k 1.4×	1.4k 1.5×	572 1.0×	157	6.7k
Josy Reiffers France	48	6.6k 1.8×	1.7k 0.8×	1.9k 1.0×	1.3k 1.4×	437 0.8×	223	9.1k
Michael B. Maris United States	50	7.8k 2.2×	1.2k 0.6×	2.8k 1.4×	2.5k 2.8×	520 0.9×	173	11.0k
Henri H. Versteeg Netherlands	37	2.4k 0.7×	1.7k 0.8×	872 0.4×	1.1k 1.3×	755 1.4×	129	7.1k

Countries citing papers authored by Jean Roy

Since Specialization

Citations

This map shows the geographic impact of Jean Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Roy more than expected).

Fields of papers citing papers by Jean Roy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Roy. The network helps show where Jean Roy may publish in the future.

Co-authorship network of co-authors of Jean Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Roy. A scholar is included among the top collaborators of Jean Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Roy. Jean Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roy, Jean, Sandra Cohen, Guy Sauvageau, et al.. (2024). A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients. Transplantation and Cellular Therapy. 31(1). 34.e1–34.e14.

Leblanc, Richard, Jean Roy, Julie Anne Côté, et al.. (2024). Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia. Cancer Medicine. 13(17). e70192–e70192. 1 indexed citations

LeBlanc, Richard, Jean Roy, Marc Lalancette, et al.. (2023). Primary or Secondary Plasma Cell Leukemia: Dismal Outcome Despite Modern Treatments. Blood. 142(Supplement 1). 3399–3399. 1 indexed citations

LeBlanc, Richard, Imran Ahmad, Jean‐Sébastien Delisle, et al.. (2022). Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD. Transplantation and Cellular Therapy. 29(1). 44.e1–44.e9. 2 indexed citations

LeBlanc, Richard, Imran Ahmad, Jean‐Sébastien Delisle, et al.. (2020). Newly diagnosed multiple myeloma patients treated with tandem auto‐allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only. Clinical Transplantation. 34(12). e14099–e14099. 6 indexed citations

Cohen, Sandra, Imran Ahmad, Jean‐Sébastien Delisle, et al.. (2020). Single UM171‐expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors. European Journal Of Haematology. 105(6). 808–811. 4 indexed citations

Cohen, Sandra, Jean Roy, Silvy Lachance, et al.. (2018). Single UM171 Expanded Cord Blood Permits Transplantation of Better HLA Matched Cords with Excellent Gvhd Relapse Free Survival. Blood. 132(Supplement 1). 4658–4658. 3 indexed citations

Bouchard, Philippe, Sandra Cohen, Imran Ahmad, et al.. (2017). Impact of Carmustine (BCNU) Substitution for Bendamustine in the Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation for the Treatment of Lymphoma. Blood. 130. 2022–2022. 2 indexed citations

Roy, Denis‐Claude, S Lachance, Jean Roy, et al.. (2016). Donor lymphocytes depleted of alloreactive T-cells (ATIR101) improve overall survival and reduce transplant related mortality in a T-cell depleted haploidentical HSCT: Results from a Phase 2 trial in patients with AML and ALL. Bone Marrow Transplantation. 51.

10.

Burgert, James, et al.. (2010). Effects of Celox and TraumaDEX on hemorrhage control in a porcine model.. PubMed. 78(2). 115–20. 16 indexed citations

11.

Fagnoni, Philippe, Nöel Milpied, Samuel Limat, et al.. (2009). Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations

12.

Massicotte, Luc, et al.. (2009). Comparison of spinal anesthesia with general anesthesia on morphine requirement after abdominal hysterectomy. Acta Anaesthesiologica Scandinavica. 53(5). 641–647. 46 indexed citations

13.

Ménard, Annie, et al.. (2006). Individual QTLs controlling quantitative variation in blood pressure inherited in a Mendelian mode. Heredity. 98(3). 165–171. 14 indexed citations

14.

Piccart, Martine, K. Bertelsen, Gavin Stuart, et al.. (2002). Long-term follow-up confirms a survival advantage of paclitaxel-cisplatin (CP) regimen over the cyclophosphamide-cisplatin (CP) combination in advanced ovarian cancer. Annals of Oncology. 5 indexed citations

15.

Gilbert, Clare, Jean Roy, Robert Bélanger, et al.. (2001). Lack of Emergence of Cytomegalovirus UL97 Mutations Conferring Ganciclovir (GCV) Resistance following Preemptive GCV Therapy in Allogeneic Stem Cell Transplant Recipients. Antimicrobial Agents and Chemotherapy. 45(12). 3669–3671. 28 indexed citations

16.

Roy, Jean, Carle Ryckman, Vincent Bernier, Renaud Whittom, & Robert Delage. (1998). Large cell lymphoma complicating persistent polyclonal B cell lymphocytosis. Leukemia. 12(7). 1026–1030. 19 indexed citations

17.

Gacel, G., et al.. (1990). Tritium labelling of highly selective probes for δ‐opioid receptors: [³H] Tyr‐D‐Ser(O‐t‐Bu)‐Gly‐Phe‐Leu‐Thr(DSTBULET) and [³H]Tyr‐D‐Ser(O‐t‐Bu)‐Gly‐Phe‐Leu‐Thr(O‐t‐Bu)(BUBU). Journal of Labelled Compounds and Radiopharmaceuticals. 28(8). 867–876. 5 indexed citations

18.

Rognan, Didier, et al.. (1987). Synthesis of S‐[³H]‐DO‐710, a benzamide ligand of the D₂‐dopamine receptor and of S‐[³H]‐azidosulpride, its photoactivable analog. Journal of Labelled Compounds and Radiopharmaceuticals. 24(11). 1361–1372. 3 indexed citations

19.

Roy, Jean, et al.. (1970). Artificial gill (cellophane-membrane coil dialyzer) in respiratory insufficiency.. PubMed. 13(3). 272–8. 1 indexed citations

20.

Roy, Jean, et al.. (1965). CARCINOMA OF THE PROSTATE. FOLLOW-UP STUDIES OF 'FRANK' AND 'LATENT' CARCINOMA.. PubMed. 44. 1–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact